ES450874A1 - Un procedimiento para la preparacion de un nuevo derivado dedopamina. - Google Patents
Un procedimiento para la preparacion de un nuevo derivado dedopamina.Info
- Publication number
- ES450874A1 ES450874A1 ES450874A ES450874A ES450874A1 ES 450874 A1 ES450874 A1 ES 450874A1 ES 450874 A ES450874 A ES 450874A ES 450874 A ES450874 A ES 450874A ES 450874 A1 ES450874 A1 ES 450874A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- dopamine derivative
- containing same
- derivative compounds
- medicine containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Dopamine derivative compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 230000008327 renal blood flow Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50100623A JPS5811853B2 (ja) | 1975-08-21 | 1975-08-21 | ドパミンユウドウタイノゴウセイホウ |
| JP51004022A JPS5858342B2 (ja) | 1976-01-19 | 1976-01-19 | ドパミン誘導体およびドパミン誘導体を含有する医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES450874A1 true ES450874A1 (es) | 1977-12-01 |
Family
ID=26337719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES450874A Expired ES450874A1 (es) | 1975-08-21 | 1976-08-20 | Un procedimiento para la preparacion de un nuevo derivado dedopamina. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4064235A (enExample) |
| DE (1) | DE2637600A1 (enExample) |
| ES (1) | ES450874A1 (enExample) |
| FR (1) | FR2321297A1 (enExample) |
| GB (1) | GB1562608A (enExample) |
| NL (1) | NL186863C (enExample) |
| SE (1) | SE7609245L (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1592552A (en) * | 1976-12-10 | 1981-07-08 | Inst Nat Sante Rech Med | Pseudopeptides used as medicaments |
| US4179434A (en) * | 1977-01-17 | 1979-12-18 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
| US4113715A (en) * | 1977-01-17 | 1978-09-12 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
| US4165320A (en) * | 1977-01-17 | 1979-08-21 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
| PH14064A (en) * | 1977-05-06 | 1981-01-26 | Pfizer | Phenylgycine derivatives,pharmaceutical compositions and method of use |
| EP0200024B1 (de) | 1985-04-30 | 1992-07-01 | ARZNEIMITTELWERK DRESDEN GmbH | 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
| US20060014697A1 (en) | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
| US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
| US7700561B2 (en) * | 2002-02-22 | 2010-04-20 | Shire Llc | Abuse-resistant amphetamine prodrugs |
| US7659253B2 (en) | 2002-02-22 | 2010-02-09 | Shire Llc | Abuse-resistant amphetamine prodrugs |
| US7105486B2 (en) * | 2002-02-22 | 2006-09-12 | New River Pharmaceuticals Inc. | Abuse-resistant amphetamine compounds |
| JP4898445B2 (ja) | 2003-05-29 | 2012-03-14 | シャイア エルエルシー | 乱用抵抗性アンフェタミン化合物類 |
| CN112770734B (zh) | 2018-09-13 | 2024-08-20 | 堪培拉大学 | 抑制方法 |
| CN111925293B (zh) * | 2020-08-24 | 2022-06-14 | 山东达冠医药科技有限公司 | 一种盐酸多巴胺的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803120A (en) * | 1971-09-28 | 1974-04-09 | Hoffmann La Roche | Di-and tripeptides of 3-(3,4-dihydroxyphenyl)-alanine |
-
1976
- 1976-08-17 US US05/715,008 patent/US4064235A/en not_active Expired - Lifetime
- 1976-08-19 SE SE7609245A patent/SE7609245L/xx not_active Application Discontinuation
- 1976-08-20 DE DE19762637600 patent/DE2637600A1/de active Granted
- 1976-08-20 ES ES450874A patent/ES450874A1/es not_active Expired
- 1976-08-23 NL NLAANVRAGE7609368,A patent/NL186863C/xx not_active IP Right Cessation
- 1976-08-23 GB GB34991/76A patent/GB1562608A/en not_active Expired
- 1976-08-23 FR FR7625486A patent/FR2321297A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2637600A1 (de) | 1977-03-03 |
| NL186863C (nl) | 1991-03-18 |
| NL7609368A (nl) | 1977-02-23 |
| FR2321297A1 (fr) | 1977-03-18 |
| FR2321297B1 (enExample) | 1979-05-18 |
| US4064235A (en) | 1977-12-20 |
| DE2637600C2 (enExample) | 1988-01-28 |
| SE7609245L (sv) | 1977-02-22 |
| GB1562608A (en) | 1980-03-12 |
| NL186863B (nl) | 1990-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7609245L (sv) | Forfarande for framstellning av dopaminderivat | |
| NO160144C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt vasotocin-derivat. | |
| RU94044534A (ru) | Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции | |
| ES475035A1 (es) | Un procedimiento para preparar derivados del acido cefalosporanico. | |
| JPS57212157A (en) | Collagenase inhibitory compound | |
| ES8800161A1 (es) | Procedimiento para la fabricacion de derivados quinolilglicinamidas | |
| ES447010A1 (es) | Procedimiento para preparar 1-(3, 3, 3-triarifpropil-4-fe- nil)-4-piperidinamotanoles. | |
| ES8105969A1 (es) | Procedimiento para preparar derivados fluorados de metil-be ta-alanina. | |
| IE38979B1 (en) | Amides derived from quinoxaline | |
| ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
| IL68525A (en) | (s)and(r,s)-4-amino-hepta-5,6-dienoic acids and salts thereof,their preparation and pharmaceutical compositions containing them | |
| ES477167A1 (es) | Un procedimiento para la preparacion de sales del acido (-)-lis-1,2,epoxipropilfosforico. | |
| GB1354584A (en) | Clear liquid laxative-antacid composition | |
| GB1463505A (en) | Pharmaceutical compositions | |
| AU557068B2 (en) | 1-aroyl-5-oxo-2-pyrrolidine propanoic acids and esters | |
| JPS5289629A (en) | Dopamine derivatives and medicaments containing the same | |
| DE3060423D1 (en) | Dipeptides for use in the treatment of diseases, some compounds of this class, medicaments containing dipeptides and their manufacture | |
| GB2008096A (en) | (2-Oxo-pyrrolidine-1)- and (2-oxo- piperidine-1) carboxylic acid hydrazides, process for the manufacture thereof, and pharmaceutical preparations containing them | |
| AU572787B2 (en) | Aphidicolin derivatives | |
| ES8304923A1 (es) | Un procedimiento para la preparacion de un peptido. | |
| GB1398819A (en) | Pharmaceutical compositions containing sulphoglycopeptide salts | |
| ES8304924A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama. | |
| IE35074L (en) | Peptides | |
| GB1178149A (en) | alpha-(N-Thiocarboxy)-Amino Acid Anhydrides | |
| GB1243474A (en) | Compositions comprising l-dopa |